Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Archives of Toxicology|November 6, 2022
Neurotoxicity evoked by organophosphates and available countermeasuresLenka Pulkrabkova, Barbora Svobodova, Jan Konecny, et al.Cell Calcium|February 25, 2019
A single point mutation in the TRPC3 lipid-recognition window generates supersensitivity to benzimidazole channel activatorsBarbora Svobodova, Michaela Lichtenegger, Dieter Platzer, et al.Scientific Reports|May 23, 2019
The effect of 808 nm and 905 nm wavelength light on recovery after spinal cord injuryBarbora Svobodova, Anna Kloudova, Jiri Ruzicka, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 23, 2025
Balancing rigidity and flexibility: Optimised 4-(hexyloxy)benzoate antagonists with enhanced affinity and tuneable duration at muscarinic receptorsEva Dolejší, Eva Mezeiova, Jana Bláhová, et al.Neuropharmacology|September 14, 2017
A green tea polyphenol epigallocatechin-3-gallate enhances neuroregeneration after spinal cord injury by altering levels of inflammatory cytokinesLucia Machova Urdzikova, Jiri Ruzicka, Kristyna Karova, et al.Biomolecules|August 22, 2019
Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase InhibitorsBarbora Svobodova, Eva Mezeiova, Vendula Hepnarova, et al.Neural Regeneration Research|February 17, 2018
Does combined therapy of curcumin and epigallocatechin gallate have a synergistic neuroprotective effect against spinal cord injury?Jiri Ruzicka, Lucia Machova Urdzikova, Barbora Svobodova, et al.ACS Medicinal Chemistry Letters|January 16, 2020
Cysteine-Targeted Insecticides against A. gambiae Acetylcholinesterase Are Neither Selective nor Reversible InhibitorsLukas Gorecki, Rudolf Andrys, Monika Schmidt, et al.Science Advances|September 13, 2021
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicineYitian Zhou, Gabriel Herras Arribas, Ainoleena Turku, et al.ACS Chemical Biology|August 25, 2023
Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide FormationMartin Novak, Marie Vajrychova, Stefania Koutsilieri, et al.Pageof 3